Skip to main content
. 2022 May 23;40(31):3593–3602. doi: 10.1200/JCO.21.02278

FIG 2.

FIG 2.

Cumulative incidence of CNS and non-CNS progression in CROWN: (A) CNS progression in patients with brain metastases at baseline and (B) CNS progression in patients without brain metastases at baseline. HR, hazard ratio.